Talent for Innovation·Est. 2001·3,000+ placements · six offices · four regions
Capital Raisingprimary sourcedetected 2026-06-12 · confidence 95%

Microba Life Sciences: Capital Raising

Microba raised A$5m at A$0.05/share with strategic validation from Sonic Healthcare investing A$1.5m. Company targeting CY2027 break-even through AI cost automation (A$700k/month) and revenue growth (A$600k/month). Also exploring therapeutics licensing deals via Boston-based advisor.

Source: Stocks Down Under

The leadership read

Will need: AI/automation engineers for cost-reduction initiatives, enterprise sales leadership for healthcare clinic contracts, VP Operations to manage cost restructuring, product launch leadership for Q3 2026 category-defining product, licensing/BD executives for therapeutics partnering process.

Market context: the MitchelLake Talent Market Index reads 108.5Hot (+10.8 vs prior month); Americas signal share is easing (-9.8pts).

MitchelLake in this thematic

Nearby in the record

Share: WhatsApp · X · Email